| Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus PGM van Gageldonk, FG van Schaijk, FR van der Klis, GAM Berbers Journal of immunological methods 335 (1-2), 79-89, 2008 | 235 | 2008 |
| Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis SC de Greeff, HE de Melker, PGM van Gageldonk, JFP Schellekens, ... PloS one 5 (12), e14183, 2010 | 203 | 2010 |
| Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in … JP van den Berg, EAM Westerbeek, GAM Berbers, PGM van Gageldonk, ... The Pediatric infectious disease journal 29 (9), 801-805, 2010 | 139 | 2010 |
| Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial MW Heijstek, S Kamphuis, W Armbrust, J Swart, S Gorter, LD de Vries, ... Jama 309 (23), 2449-2456, 2013 | 125 | 2013 |
| Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus GP Smits, PG van Gageldonk, LM Schouls, FRM van der Klis, ... Clinical and Vaccine Immunology 19 (3), 396-400, 2012 | 113 | 2012 |
| Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine RM de Voer, L Mollema, RM Schepp, SC de Greeff, PGM van Gageldonk, ... PloS one 5 (8), e12144, 2010 | 94 | 2010 |
| Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross … MW Heijstek, PGM van Gageldonk, GAM Berbers, NM Wulffraat Annals of the rheumatic diseases 71 (6), 948-954, 2012 | 90 | 2012 |
| Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial J Spijkerman, RH Veenhoven, AJ Wijmenga-Monsuur, KEM Elberse, ... Jama 310 (9), 930-937, 2013 | 83 | 2013 |
| Epitope Structure of the Bordetella pertussis Protein P.69 Pertactin, a Major Vaccine Component and Protective Antigen M Hijnen, FR Mooi, PGM van Gageldonk, P Hoogerhout, AJ King, ... Infection and immunity 72 (7), 3716-3723, 2004 | 78 | 2004 |
| G-proteins mediate intestinal chloride channel activation BC Tilly, M Kansen, PG Van Gageldonk, N Van Den Berghe, H Galjaard, ... Journal of Biological Chemistry 266 (4), 2036-2040, 1991 | 63 | 1991 |
| The Bordetella pertussis virulence factor P. 69 pertactin retains its immunological properties after overproduction in Escherichia coli M Hijnen, PGM van Gageldonk, GAM Berbers, T van Woerkom, FR Mooi Protein expression and purification 41 (1), 106-112, 2005 | 55 | 2005 |
| Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study EM Swart, PGM Van Gageldonk, HE De Melker, FR Van Der Klis, ... PLoS One 11 (2), e0148605, 2016 | 54 | 2016 |
| Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of: Bordetella pertussis: Despite High Vaccination Rates S Scott, M van der Sande, T Faye-Joof, M Mendy, B Sanneh, FB Jallow, ... The Pediatric infectious disease journal 34 (4), 333-338, 2015 | 46 | 2015 |
| Direct comparison of immunogenicity induced by 10-or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants AJ Wijmenga-Monsuur, E van Westen, MJ Knol, RMC Jongerius, ... PloS one 10 (12), e0144739, 2015 | 45 | 2015 |
| Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries G Berbers, P van Gageldonk, J Kassteele, U Wiedermann, I Desombere, ... Nature communications 12 (1), 2871, 2021 | 42 | 2021 |
| A Competitive Enzyme-Linked Immunosorbent Assay for Measuring the Levels of Serum Antibody to Haemophilus influenzae Type b M Mariani, E Luzzi, D Proietti, S Mancianti, D Casini, P Costantino, ... Clinical Diagnostic Laboratory Immunology 5 (5), 667-674, 1998 | 42 | 1998 |
| A novel strategy to mimic discontinuous protective epitopes using a synthetic scaffold M Hijnen, DJ van Zoelen, C Chamorro, P van Gageldonk, FR Mooi, ... Vaccine 25 (37-38), 6807-6817, 2007 | 40 | 2007 |
| High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study A Steens, L Mollema, GAM Berbers, PGM Van Gageldonk, ... Vaccine 28 (49), 7803-7809, 2010 | 37 | 2010 |
| The role of peptide loops of the Bordetella pertussis protein P. 69 pertactin in antibody recognition M Hijnen, R de Voer, FR Mooi, R Schepp, EE Moret, P van Gageldonk, ... Vaccine 25 (31), 5902-5914, 2007 | 33 | 2007 |
| Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid PGM van Gageldonk, C von Hunolstein, FRM van der Klis, GAM Berbers Clinical and Vaccine Immunology 18 (7), 1183-1186, 2011 | 31 | 2011 |
Guy BerbersVerified email at rivm.nl
